Lexicon Pharmaceuticals Inc (LXRX) earnings · rev $49.8M
These earnings events as JSON? API free 100/dayLexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
This LXRX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LXRX revenue for 2025-12-31 was $49.8M. Net income was -$50.3M. Revenue was up 60.2% from 2024-12-31 to 2025-12-31. LXRX currently screens at market cap $327.2M.
When the next LXRX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 60.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full LXRX research stays on the stock page; the tape stays on the quote page.
LXRX earnings FAQ
What are LXRX's latest revenue and net income?
Latest cached Lexicon Pharmaceuticals Inc (LXRX) revenue for Dec 31, 2025 was $49.8M. Net income was -$50.3M. Statements: https://lician.com/financials/lxrx
What is LXRX's latest diluted EPS?
Latest cached Lexicon Pharmaceuticals Inc (LXRX) diluted EPS for Dec 31, 2025 was -$0.14.
What period does the latest LXRX earnings print cover?
The latest cached Lexicon Pharmaceuticals Inc (LXRX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did LXRX revenue change from the prior cached period?
Cached Lexicon Pharmaceuticals Inc (LXRX) revenue was up 60.2% from $31.1M (Dec 31, 2024) to $49.8M (Dec 31, 2025). Statements: https://lician.com/financials/lxrx
Where are LXRX earnings listed?
Cached earnings facts for Lexicon Pharmaceuticals Inc (LXRX) are listed at https://lician.com/earnings/lxrx. Statements: https://lician.com/financials/lxrx
Not investment advice.